Yanelly Pharmaceuticals Private Limited

Yanelly Pharmaceuticals Private Limited - chemicals in Bhopal, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U24304MP2016PTC041740 Incorporated 28 October 2016 ROC Gwalior HQ Bhopal, Madhya Pradesh, India
Active Private Limited Company chemicals
Revenue · FY 2024
₹12.73 Lakh
▲ 10% YoY
Net profit · FY 2024
₹19,656
Net margin 1.5%
EBITDA · FY 2024
₹26,837
EBITDA margin 2.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Yanelly Pharmaceuticals Private Limited

Data last updated:

Yanelly Pharmaceuticals Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 28 October 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24304MP2016PTC041740. Its GSTIN is 23AAACY8400B1ZW (Madhya Pradesh).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Deepak Kumar Mishra and Mani Khatri.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bhopal, Madhya Pradesh.

As per the financials filed for FY 2024, the company reported a revenue of ₹12.73 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹19,656 (net margin 1.5%) and EBITDA of ₹26,837 (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 17% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24304MP2016PTC041740
Registration Number 041740
Incorporation Date 28 October 2016
ROC Gwalior
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Yanelly Pharmaceuticals Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    H.N.B – 1/401 Fortune Signature E – 8 Bawadiya Kala, N, Bhopal, Madhya Pradesh, India – 462039
  • Industry
    Chemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products

To see the full contact details of Yanelly Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Yanelly Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Yanelly Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Yanelly Pharmaceuticals Private Limited, buy the company report.

Financials of Yanelly Pharmaceuticals Private Limited

FY 2025 filings available

Yanelly Pharmaceuticals Private Limited reported revenue of ₹12.73 Lakh (up 10% YoY) for FY 2024.

Revenue · FY 2024
₹12.73 Lakh ▲ 10%
Net profit · FY 2024
₹19,656 margin 1.5%
EBITDA · FY 2024
₹26,837 margin 2.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 21%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 20%
5 years · compounded
▲ 37%

Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 10% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹26,837
Profit Before Tax
Tax Expense
Net Profit (PAT)₹19,656
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin2.1%
Net Profit Margin1.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Yanelly Pharmaceuticals Private Limited, buy the company report.

Board of directors of Yanelly Pharmaceuticals Private Limited

Yanelly Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Deepak Kumar MishraDirector28 Oct 201610 Years 0 MonthsCurrent
Mani KhatriDirector25 Mar 20233 Years 7 MonthsCurrent

Auditor

Yanelly Pharmaceuticals Private Limited is audited by Mayank Kesharwani & Company for the financial year 2017.

Auditor firmFinancial yearFirm registration number
Mayank Kesharwani & CompanyFY 2017021949C

Shareholding

The shareholding of Yanelly Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Yanelly Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Yanelly Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Yanelly Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AAACY8400B1ZWMadhya PradeshActive26 Aug 2017

To see the full GST registrations and return filing status of Yanelly Pharmaceuticals Private Limited, buy the company report.

Recent activity

Yanelly Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Mani Khatri ceased to be Additional Director on 29 Sep 2023.

AGM
Yanelly Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Yanelly Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Ceased
Mani Khatri ceased to be Additional Director.
Ceased
Kapil Khatri ceased to be Director.
Appointed
Mani Khatri was appointed as Director.
Appointed
Deepak Kumar Mishra was appointed as Director.
Incorporation
28 Oct 2016
Yanelly Pharmaceuticals Private Limited was registered on 28 Oct 2016 with Roc Gwalior & aged 10 years 20 days as per MCA records.

Frequently asked questions

Yanelly Pharmaceuticals is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 28 October 2016 (10+ years old) and is registered under CIN U24304MP2016PTC041740.

Yanelly Pharmaceuticals has 2 current directors:

The latest financial statements of Yanelly Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Yanelly Pharmaceuticals is 23AAACY8400B1ZW, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Yanelly Pharmaceuticals is U24304MP2016PTC041740. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yanelly Pharmaceuticals was incorporated on 28 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Gwalior.

Mani Khatri ceased to be Additional Director on 29 Sep 2023. Kapil Khatri ceased to be Director on 25 Mar 2023. Mani Khatri was appointed as Director on 25 Mar 2023. Yanelly Pharmaceuticals has 4 board changes on record in total.

The registered office of Yanelly Pharmaceuticals is at H.N.B – 1401 Fortune Signature E – 8 Bawadiya Kala, N, Bhopal, Madhya Pradesh, India – 462039.

Yanelly Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.

The compliance status of Yanelly Pharmaceuticals is compliant as of 17 August 2026. The company is actively filing with the Registrar of Companies.